1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
611648885FFC7ACAA85256EB000609543
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/key-factors-in-recruiting-and-retaining-patients-for-clinical-trials?opendocument
18
19opendocument
2044.210.149.218
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25DB




» Products & Services » » Clinical Operations » Patient Recruitment and Retention for Clinical trials

Key Factors in Recruiting and Retaining Patients for Clinical Trials

DB Image

ID: 4673


Features:

Graphics


Pages/Slides: 29


Published: Pre-2019


Delivery Format: Online PDF Document


 

License Options:


Buy Now

 

919-403-0251

  • STUDY OVERVIEW
  • BENCHMARK CLASS
  • BROWSE SELECTED PAGES
  • SPECIAL OFFER
Study Overview

Effective clinical trial communication enhances study sites’ ability to rapidly enroll patients and successfully retain them throughout the trial. Market research techniques that develop patient profiles are needed in order to select the most effective message and communication channels to recruit patients. Pharmaceutical companies can then determine where ideal patients are geographically, profile the most appropriate patients for the therapeutic area, and employ media use statistics to determine the appropriate advertising channel. This 29-page document details how high-performing pharmaceutical companies work closely with all points of contact to successfully engage and enroll patients, support retention efforts, and manage recruitment and retention performance.

Key Topics

  • creating an appropriate media strategy towards patient population
  • identifying patient participation factors
  • patient recruitment training
  • incentives programs and encouraging recruitment
  • motivation factors for patient compliance and completion of study
  • addressing patient concerns
  • patient relationship building

Sample Best Practices
  • Advertise early in the recruitment period to avoid downstream recruitment problems.
    *One company develops recruitment advertisements before the recruitment stage to avoid potential delays.
  • Provide incentives based on patients’ motivation to complete the study.
    *According to study site coordinators, patients appreciate small but meaningful rewards given to them throughout the study. Such rewards include financial compensation, travel and parking expenses, meal expenses, gift certificates, disease treatment, and free follow-up visits.
  • Communicate site performance and study progress through newsletters or study web sites to drive study momentum.
    *One benchmark partner sends monthly newsletters detailing patient enrollment status to all sites. “It’s amazing how you can motivate a site by listing the coordinator or investigator’s name, their site name and the number of patients enrolled in rank order,” said one executive. He also noted, however, that pharmaceutical companies and CROs must be careful to encourage, not publicly humiliate, sites that are under-performing.
Methodology
This research results from a Best Practices, LLC consulting project.

Industries Profiled:
Pharmaceutical; Manufacturing; Biotech; Consumer Products; Diagnostic; Medical Device; Health Care; Research; Professional Services


Companies Profiled:
AstraZeneca; Sanofi-aventis; Bayer; Bristol-Myers Squibb; Eli Lilly and Company; GlaxoSmithKline; Pfizer; Roche; Trimeris; aaiPharma; America's Doctor; BBK Healthcare; Covance; Health Decisions; PPD

Browse Selected Pages
Click on an image below to see the full PDF version

Cover Page
Cover Page
Sample Page 1
Sample Page 1
Sample Page 2
Sample Page 2

If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.